Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 540-546

  Yang, Bo ^a   Fan, Lingling ^a   Fang, Liang ^a   He, Qiaojun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

4 HPR; ALL; Drug resistance; Hypoxia

Indexed keywords

FENRETINIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROCASPASE 3; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXIA; IC 50; LEUKEMIA CELL LINE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL HYPOXIA; CELL LINE, TUMOR; FENRETINIDE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MITOCHONDRIAL MEMBRANES;

EID: 33745726211     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0197-6     Document Type: Article

References (32)

1. Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169-180
2. O'Donnell PH, Guo WX, Reynolds CP, Maurer BJ (2002) N-(4-hydroxyphenyl) retinamide increases ceram ide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. Leukemia 16:902-910
3. Sabichi AL, Hendricks DT, Bober MA, Birrer MJ (1998) Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J Natl Cancer Inst 90:597-605
4. Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M, Bernassola F, Piacentini M, Malcolm AJ, Pearson AD, Melino G, Redfern CP (2000) Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res 260:50-60
5. Sun SY, Li W, Yue P, Lippman SM, Hong WK, Lotan R (1999) Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 59:2493-2498
6. Chen YR, Zhou G, Tan TH (1999) c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide. Mol Pharmacol 56:1271-1279
7. Lovat PE, Ranalli M, Bernassola F, Tilby M, Malcolm AJ, Pearson AD, Piacentini M, Melino G, Redfern CP (2000) Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs. Int J Cancer 88:977-985
8. Senchenkov A, Litvak DA, Cabot MC (2001) Targeting ceramide metabolism - a strategy for overcoming drug resistance. J Natl Cancer Inst 93:347-357
9. Buchanan GR, Rivera GK, Pollock BH, Boyett JM, Chauvenet AR, Wagner H, Maybee DA, Crist WM, Pinkel D (2000) Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission. Cancer 88:1166-1174
10. Chessells JM, Veys P, Kempski H, Henley P, Leiper A, Webb D, Hann IM (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 123:396-405
11. Yang B, Keshelava N, Anderson CP, Reynolds CP (2003) Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Cancer Res 63:1520-1526
12. Dachs GU, Tozer GM (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 36: 1649-1660
13. Brown JM, Koong A (1991) Therapeutic advantage of hypoxic cells in tumors: a theoretical study. J Natl Cancer Inst83:178-185
14. Batra S, Reynolds CP, Maurer BJ (2004) Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Cancer Res 64:5415-5424
15. Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Floyd RA, Broyles RH (2005) Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic Biol Med 39:641-650
16. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K (2001) Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 276:12076-12083
17. Serafino A, Sinibaldi-Vallebona P, Lazzarino G, Tavazzi B, Di Pierro D, Rasi G, Ravagnan G (2000) Modifications of mitochondria in human tumor cells during anthracycline-induced apoptosis. Anticancer Res 20:3383-3394
18. Poulaki V, Mitsiades N, Romero ME, Tsokos M (2001) Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res 61:4864-4872
19. Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366:151-165
20. Yang CF, Shen HM, Ong CN (2000) Intracellular thiol depletion causes mitochondrial permeability transition in ebselen-induced apoptosis. Arch Biochem Biophys 380:319-330
21. Zou H, Li Y, Liu X, Wang X (1999) An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549-11556
22. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446
23. Miranda MB, Dyer KF, Grandis JR, Johnson DE (2003) Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-XL and XIAP in the prolonged survival of monocytic cells. Leukemia 17:390-400
24. Yang YL, Li XM (2000) The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10:169-177
25. Gardai SJ, Whitlock BB, Xiao YQ, Bratton DB, Henson PM (2004) Oxidants inhibit ERK/MAPK and prevent its ability to delay neutrophil apoptosis downstream of mitochondrial changes and at the level of XIAP. J Biol Chem 279:44695-44703
26. Grant JL, Smith B (1963) Bone marrow gas tensions, bone marrow blood flow, and erythropoiesis in man. Ann Intern Med 58:801-809
27. Chou J, Chou TC (eds) (1988) Dose effect analysis with microcomputers. Elsevier-Biosoft, Cambridge
28. Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB, Hockenbery DM (1997) Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 138:449-469
29. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP (1999) Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst 91:1138-1146
30. Faderl S, Lotan R, Kantarjian HM, Harris D, Van Q, Estrov Z (2003) N-(4- Hydroxylphenyl)retinamide fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Leuk Res 27:259-266
31. Lin H, Chen C, Li X, Chen BD (2002) Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein. Exp Cell Res 272:192-198
32. Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E, Andreeff M (2001) Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest 108:851-859